134 results on '"H, Niizeki"'
Search Results
2. 421 Genotype-phenotype correlation analysis in Japanese patients with pachydermoperiostosis
- Author
-
R. Tanaka, H. Niizeki, T. Nomura, A. Seki, S. Narumi, K. Nakabayashi, and K. Yoshida
- Subjects
Cell Biology ,Dermatology ,Molecular Biology ,Biochemistry - Published
- 2023
- Full Text
- View/download PDF
3. 043 Role of Prostaglandin E-major Urinary Metabolite Levels in Identifying The Phenotype of Pachydermoperiostosis
- Author
-
M. Ishibashi, T. Oiwa, T. Nomura, Y. Yoshikawa, H. Niizeki, and K. Kabashima
- Subjects
Cell Biology ,Dermatology ,Molecular Biology ,Biochemistry - Published
- 2021
- Full Text
- View/download PDF
4. The complete type of pachydermoperiostosis: A novel nonsense mutation p.E141* of the SLCO2A1 gene
- Author
-
Akira Ishiko, Jun Kudoh, Masayuki Amagai, Keisuke Kosaki, Atsuhito Seki, Keiji Tanese, A. Ogo, Aiko Shiohama, Taketo Yamada, H. Niizeki, Kenji Kabashima, Masayuki Miyasaka, Asami Hirakiyama, Torayuki Okuyama, K. Nakabayashi, Maiko Matsuda, Takashi Sasaki, Kentaro Matsuoka, and Atsushi Otsuka
- Subjects
Genetics ,biology ,business.industry ,media_common.quotation_subject ,Nonsense ,Nonsense mutation ,Intron ,Heterozygote advantage ,Dermatology ,Biochemistry ,Exon ,biology.protein ,Cancer research ,Medicine ,Allele ,business ,Molecular Biology ,Gene ,media_common ,SLCO2A1 - Published
- 2014
- Full Text
- View/download PDF
5. The novelSLCO2A1heterozygous missense mutation p.E427K and nonsense mutation p.R603* in a female patient with pachydermoperiostosis with an atypical phenotype
- Author
-
Keiji Tanese, Asami Hirakiyama, Takashi Sasaki, Masayuki Amagai, Akira Ishiko, M. Takeshita, Atsuhito Seki, Aiko Shiohama, Jun Kudoh, Atsushi Otsuka, H. Niizeki, Kenji Kabashima, and Torayuki Okuyama
- Subjects
Genetics ,biology ,business.industry ,Nonsense mutation ,Heterozygote advantage ,Dermatology ,medicine.disease ,Phenotype ,Spinal osteoarthropathy ,Mutation (genetic algorithm) ,Female patient ,biology.protein ,Missense mutation ,Medicine ,business ,SLCO2A1 - Published
- 2014
- Full Text
- View/download PDF
6. Unusually located lymphocutaneous nocardiosis caused by Nocardia brasiliensis
- Author
-
Tomoo Fukuda, Shunichi Miyakawa, Takeji Nishikawa, W. Naka, Yuzuru Mikami, and H. Niizeki
- Subjects
Male ,Pathology ,medicine.medical_specialty ,Nocardia Infections ,Dermatology ,Nocardia ,Japan ,Skin abrasions ,medicine ,Humans ,Lymphatic Diseases ,Aged ,Aged, 80 and over ,integumentary system ,biology ,Nocardia brasiliensis ,business.industry ,Nocardiosis ,Skin Diseases, Bacterial ,Minocycline ,medicine.disease ,biology.organism_classification ,Nocardiaceae ,Actinomycosis ,business ,Skin lesion ,medicine.drug - Abstract
We report a patient with primary lymphocutaneous Nocardia brasiliensis infection affecting the face and left arm. The mode of infection was via skin abrasions which occurred 2 weeks prior to the development of the skin lesions. Treatment with intravenous minocycline for 4 weeks resulted in a cure. We also review 12 previously reported Japanese cases of lymphocutaneous nocardiosis.
- Published
- 2006
- Full Text
- View/download PDF
7. Lack of association of the interleukin-1 receptor antagonist gene with palmoplantar pustulosis in Japanese
- Author
-
H. Niizeki, K. Hashigucci, Takeji Nishikawa, H. Inoko, N. Inamoto, M. Yokoyama, and T. Naruse
- Subjects
Palmoplantar pustulosis ,medicine.drug_class ,Immunology ,Interleukin ,Biology ,Receptor antagonist ,Pathogenesis ,Interleukin 1 receptor antagonist ,Polymorphism (computer science) ,Genotype ,Genetics ,medicine ,Tumor necrosis factor alpha - Abstract
We analysed a polymorphism of the interleukin (IL)-1 receptor antagonist (IL1RN) gene in 93 Japanese patients with palmoplantar pustulosis (PPP). None of the IL1RN alleles was significantly increased in the patients compared with controls. Because PPP has been reported to be associated with the tumour necrosis factor (TNF) region, we examined the association between the TNF and IL1RN genes. There was a difference in IL1RN*2 positivity between patients with and without the AA genotype of the TNF gene. In contrast, such a difference was not found in controls. These data indicate a possible epistatic effect between TNF and IL1RN linked genes for susceptibility to the pathogenesis of PPP.
- Published
- 2003
- Full Text
- View/download PDF
8. Genotyping for HLA-A, B and C alleles in Japanese patients with pemphigus: prevalence of Asian alleles of the HLA-B15 family
- Author
-
T. Kaneshige, Sachiko Miyagawa, H. Niizeki, and Yukio Yamashina
- Subjects
Genetics ,education.field_of_study ,Linkage disequilibrium ,Population ,Pemphigus vulgaris ,Dermatology ,Human leukocyte antigen ,Biology ,medicine.disease ,HLA-A ,immune system diseases ,Genotype ,Immunology ,medicine ,skin and connective tissue diseases ,education ,Genotyping ,Pemphigus foliaceus - Abstract
Summary Background There have been only limited reports on major histocompatibility complex class I antigens in pemphigus. Objectives To characterize HLA-A, B and C class I alleles by genotyping in Japanese patients with pemphigus, and to analyse the possible association of class I alleles with disease susceptibility within a relatively homogeneous ethnic population. Methods Alleles of HLA-A, B and C, and DRB1 and DQB1 loci were fully determined in 51 Japanese patients with pemphigus. Results Asian alleles of the HLA-B15 family, including the allele B*1507, which was significantly increased in comparison with normal controls, were prevalent in patients with pemphigus vulgaris (PV). The prevalence of B*15 alleles in patients with PV was not due to linkage disequilibrium with HLA-DR4 or DR14 alleles, which have been shown to confer strong susceptibility to PV across racial barriers. In contrast to the unique distribution of the HLA-B alleles, HLA-A and C alleles were unremarkable in patients with PV when compared with normal control subjects. Conclusions These results suggest that there may be differences in the ethnic concentrations of different HLA-B alleles in patients with PV.
- Published
- 2002
- Full Text
- View/download PDF
9. Polymorphisms in the tumor necrosis factor (TNF) genes are associated with susceptibility to effects of ultraviolet-B radiation on induction of contact hypersensitivity
- Author
-
Iwao Kurimoto, J.R. Taylor, Tadamichi Shimizu, Hidetoshi Inoko, H. Niizeki, Yuichiro Yamasaki, J W Streilein, Taeko Naruse, and K.H. Hecker
- Subjects
integumentary system ,Immunology ,Promoter ,Single-nucleotide polymorphism ,Locus (genetics) ,General Medicine ,Human leukocyte antigen ,Biology ,Biochemistry ,Molecular biology ,Genetics ,Immunology and Allergy ,Gene polymorphism ,Allele ,Allele frequency ,Gene - Abstract
We investigated the allelic distributions of single nucleotide polymorphisms (SNPs) of the TNFA, TNFB and IKBL genes, 3 microsatellites within the tumor necrosis factor (TNF) region of HLA locus, and the HLA phenotypes as well as the TLR4 gene in Chromosome 9 in 26 healthy Caucasian volunteers. These individuals were also assessed as ultraviolet B (UVB)-susceptible (S) or UVB-resistant (R). Our results identified 12 UVB-S and 14 UVB-R individuals. Attempts to correlate particular HLA-A, -B, -C, and -DR antigens with the UVB phenotypes failed. Similarly, attempts to correlate SNP at the NcoI-RFLP within intron 1 of the TNFB, IKBL and TLR4 gene with UVB phenotypes also failed. However, microsatellite analyses of TNFa, TNFc, and TNFd markers revealed a significant increase in the frequencies of TNFa2 in UVB-S individuals (P=0.00032) and of TNFd3 in UVB-R individuals (P=0.012). Moreover, DNA sequencing analyses of 5 SNPs of the TNFA promoter region revealed a significant increase in the frequency of the allele B of the TNFA gene (TNFApB) representing the nucleotide A at position -863 and C at position -1031 (P=0.015). Since it is known that TNFa2 and TNFApB is a high TNF-alpha responder, whereas TNFd3 is a TNF-alpha low responder, we propose that the TNF region of HLA contains polymorphic genes that confer susceptibility and resistance to the deleterious effects of UVB radiation on the induction of contact hypersensitivity. This proposal is consistent with previous reports that a unique microsatellite region of the Tnfa gene in mice contains alleles that dictate the UVB-dependent phenotypes in mice, and implicate TNF-alpha as the primary mediator of the immune-damaging effects of UVB radiation.
- Published
- 2001
- Full Text
- View/download PDF
10. Polymorphisms in the TNFA promoter region is not associated with palmoplantar pustulosis
- Author
-
T. Tojo, T. Urushibara, K. Hashigucci, H. Niizeki, K. Akiya, M. Yokoyama, Takeji Nishikawa, Hidetoshi Inoko, Y. Yamazaki, Yuichiro Yamasaki, and Taeko Naruse
- Subjects
Genetics ,Immunology ,Intron ,Single-nucleotide polymorphism ,Promoter ,General Medicine ,Biology ,Biochemistry ,law.invention ,Genetic marker ,law ,Genotype ,Immunology and Allergy ,Enhancer ,Gene ,Polymerase chain reaction - Abstract
Polymorphisms of the 5′-flanking promoter/enhancer region of the TNFA gene were determined in 80 Japanese patients with pulmoplantar pustulosis (PPP). The 5′-flanking region of the TNFA gene from –1107 to –66 was amplified by polymerase chain reaction (PCR) method. Nucleotide sequencing data from the PCR products revealed that 5 single nucleotide polymorphisms at position –1031, –863, –857, –307 and –237. None of the nucleotide substitutions were significantly increased in PPP patients when compared with those in controls. To clarify the linkage among the neighboring genetic marker, we analyzed the association between the polymorphisms in the TNFA promoter region and the NcoI polymorphism in the first intron of the TNFB gene as well as HLA-DR9. The genotype at –1031C is strongly associated with TNFB1 and negatively associated with TNFB2 which is reported to be associated with PPP. These data indicate that TNFA gene centromeric to TNFB is not associated with PPP and the susceptible gene of PPP is located between TNFB and HLA-B.
- Published
- 2000
- Full Text
- View/download PDF
11. Distinct roles for transforming growth factor‐β2and tumour necrosis factor‐α in immune deviation elicited by hapten‐derivatized antigen‐presenting cells
- Author
-
J W Streilein, H. Niizeki, and K.H. Hecker
- Subjects
Necrosis ,medicine.medical_treatment ,Immunology ,Antigen-Presenting Cells ,Biology ,Dermatitis, Contact ,Mice ,Transforming Growth Factor beta ,Immune Tolerance ,medicine ,Animals ,Immunology and Allergy ,Macrophage ,Antigen-presenting cell ,Mice, Inbred BALB C ,Reverse Transcriptase Polymerase Chain Reaction ,Tumor Necrosis Factor-alpha ,Original Articles ,Molecular biology ,In vitro ,Cytokine ,biology.protein ,Dinitrofluorobenzene ,medicine.symptom ,Antibody ,Haptens ,Hapten ,Transforming growth factor - Abstract
The role of antigen-presenting cells (APC) in the induction of antigen-specific unresponsiveness was examined, using two functionally distinct murine macrophage hybridomas, #59 and #63 cells. Derivatized with the hapten (dinitrofluorobenzene; DNFB), #59 cells induced contact hypersensitivity (CH) in mice. Hapten-derivatized #63 cells failed to induce CH. Instead, they prevented recipients from acquiring CH when exposed subsequently to a sensitizing dose of the hapten. Similarly, hapten-derivatized #59 cells, pretreated in vitro with transforming growth factor-beta2 (TGF-beta2) lost their capacity to evoke CH, and induced tolerance. Hapten-derivatized #63 cells and TGF-beta2-treated #59 cells eliminated CH in mice sensitized to hapten. Reverse transcription-polymerase chain reaction analysis of mRNAs for various accessory molecules important in T-cell activation revealed that #63 and TGF-beta2-treated #59 cells differed only in their expression of tumour necrosis factor-alpha (TNF-alpha) mRNA. The latter expressed higher levels of TNF-alpha mRNA than did untreated #59 cells. As a consequence, #63 and TGF-beta2-treated #59 cells, both of which induce tolerance, secrete TNF-alpha protein unlike untreated #59 cells, which do not induce tolerance to hapten. Since neutralizing anti-TNF-alpha antibodies abrogated the tolerogenic potential of #63 cells in vivo, we conclude that TGF-beta2 equips hapten-bearing APC with the capacity to evoke systemic immune deviation in which CH is selectively silenced. We speculate that one effect of TGF-beta2 is to cause APC to up-regulate TNF-alpha production. In turn, this cytokine biases the functional property of responding hapten-specific T cells in a direction that not only interferes with acquisition, but suppresses induction of CH.
- Published
- 1999
- Full Text
- View/download PDF
12. Calcitonin gene-related peptide is necessary for ultraviolet B-impaired induction of contact hypersensitivity
- Author
-
H Niizeki, P Alard, and J W Streilein
- Subjects
Immunology ,Immunology and Allergy - Abstract
Since nerve termini on Langerhans cells (LC) contain calcitonin gene-related peptide (CGRP), and since ultraviolet B radiation (UVR) causes CGRP to be released from cutaneous nerve endings, we examined whether CGRP participates in the immune aberrations caused in skin by UVR. First, intradermally injected CGRP, in a dose-dependent manner, reduced LC density and impaired CH induction when hapten was painted on the injected site. Second, CGRP antagonist restored CH induction after UVR. Third, anti-TNF-alpha Abs injected before CGRP prevented the loss of LC density and restored CH induction. Fourth, CGRP failed to impair CH induction in mast cell-deficient mice. Fifth, CGRP induced mast cells to release TNF-alpha. We conclude that CGRP plays an essential role in the loss of CH induction after UVR. These data indicate that UVR, by causing the release of CGRP from cutaneous nerve endings, triggers mast cell release of TNF-alpha, which impairs CH induction.
- Published
- 1997
- Full Text
- View/download PDF
13. 77th Annual Meeting of the Swiss Society for Dermatology and Venereology
- Author
-
M.J. Zalla, S.H. Ahmad, R. Caputo, G.F. Buezo, E. Rodríguez Díaz, K. Watanabe, H.-O Kim, R. Panizzon, J. Fraga, J.-H. Shim, C.-W. Kim, P.A. de Viragh, G. Fernández Blasco, J.M. Bonnetblanc, C. Lavignac, T. Pillar, A. Torrelo, P.F. Peñas, A. Etzioni, F. Loconsole, H. Steinert, S. Tajima, M.J. Yadlowsky, M. Mastrolonardo, S. Fuentes, M. Landthaler, A. Jetten, F. Rollé, P. Masellis, A. Ishiko, E. Frenk, H. Shimizu, P. Zenarola, K.M. Cheema, T. Nishikawa, T. Hashimoto, A. Gilhar, D. Perrenoud, J. Mausset, K. Holubar, A. Pfau, C. Santonja, J.M. Schmitt, A. García-Diez, F. Pasche-Koo, K. Shimizu, M. Lospalluti, M.T. Castilla, W. Thürlimann, P. Elsner, G. Gasparini, S.A. Ahmad, E. Daudén, R.K. Winkelmann, E. Alessi, S. Ahmad, E. Tur, R. Dummer, D. Hohl, J.M. Sanzo, H. Niizeki, M. Carotenuto, A. Conte, O.S. Gluck, M. Khayyami, N. Hunziker, R.F. Bonner, H. Yamada, R. A. Huch Böni, M. Lomuto, J.J. Zone, M. Armijo, M. Bisceglia, T.-Y. Kim, G. Burg, L. Melillo, D. Roger, R. Schultheiss, T.A. Syed, Th. Hunziker, Chang Woo Lee, A. Martín Pascual, R. Böni, G. K. von Schulthess, F. Rantuccio, A. Rebora, E. Aizen, T. Fukuda, and A.J. Bircher
- Subjects
medicine.medical_specialty ,Venereology ,business.industry ,medicine ,Dermatology ,business - Published
- 1995
- Full Text
- View/download PDF
14. Contents, Vol. 189, Supplement 1, 1994
- Author
-
S. Miyagawa, I.M. Freedberg, H. Yagi, M. Amagai, I.M. Leigh, K.D. Cooper, R.O. Perelman, M. Takata, S. Flanagan, Y. Morita, I. Palmer, T. Reunala, S. Imamura, A. Iwamatsu, J.A. McGrath, J. Salas, P. Whitehead, S. Nishiyama, H. Nakano, H. Kaya, M. Meurer, T. Hirone, T. Nishikawa, F. Wojnarowska, F. Furukawa, H. Hintner, K. Kitamura, T.B. Taylor, K. Nakamura, K. Maruyama, S. Fujiwara, M. Takigawa, J.S. Pasricha, A. Nakabayashi, E. Becker, C. Wilson, T. Ohta, N.K. Mehra, Y. Sei, R. Prussick, I. Takiuchi, K. Tamai, G.J. Giudice, L.S. Chan, N.X. Nham, H. Shinkai, K. Nishioka, M. Inaoki, C. Hammerberg, J.-Z. Zhang, R.A.J. Eady, R.P. Hall, G. Pohla-Gubo, B.S. Bhogal, A. Nakagawa, H. Ogawa, L.J. Meyer, P. Collier, M. Shodo, A. Mohimen, K. Watanabe, H. Niizeki, Y. Kitajima, J. Allen, H. Ohno, K. Kohno, K. Holubar, M.J. Rico, M. Sakuma, J. Ninomiya, J.B. Smith, M. Ohtsuki, P. Fritsch, S. Shirahama, K. Owaribe, H.Y. Choi Do, H. Yaoita, S. Kárpáti, N. Matsuyoshi, A. Ranki, L.A. Diaz, S. Morioka, E. Pazderka Smith, G. Kick, R.E. Jenkins, S.A. Vaughan Jones, G. Kirtschig, K. Li, N. Romani, T. Hashimoto, K. Iwatsuki, E.G. Zappi, F. Kaneko, Razzaque Ahmed, J.R. Stanley, K. Bhol, S. Koskimies, A. Ishiko, M.L. McCord, T. Shirai, J.J. Zone, N. Inamoto, H. Shimizu, K. Tsuchimoto, T. Wang, T. Yamamoto, K. Otoyama, Y. Mitsuhashi, I. Katayama, T. Tanaka, Z. Liu, R.D. Sontheimer, M.M. Black, J. Rodenas, D. Powell, J. Uitto, D. Sawamura, G. Messer, H. Kanauchi, T. Kawashima, S. Ishimaru, T. Ebihara, X.-S. Wang, K. Hanada, T. Murai, H. Harada, Y. Hirako, T.-S. Lieu, I. Hashimoto, M. Blumenberg, S. Kawana, T. Matsunaga, and S. Izaki
- Subjects
Dermatology - Published
- 1994
- Full Text
- View/download PDF
15. A case of bovine sex cord tumour with annular tubules
- Author
-
K. Kadota, S. Ishino, N. Hashimoto, and H. Niizeki
- Subjects
Ovarian Neoplasms ,Granulosa cell differentiation ,Pathology ,medicine.medical_specialty ,General Veterinary ,Cattle Diseases ,Right ovary ,Sex cord tumour with annular tubules ,Anatomy ,Biology ,medicine.disease ,Pathology and Forensic Medicine ,Microscopy, Electron ,medicine.anatomical_structure ,medicine ,Animals ,Immunohistochemistry ,Cattle ,Female ,Basal lamina ,Hyaline ,Testosterone ,Granulosa Cell Tumor - Abstract
A case of sex cord tumour with annular tubules was found in the right ovary of a 17-month-old Holstein cow. The tumour was characterized by tubules encircling hyaline bodies, which were composed of concentric lamellae of basal lamina. Several irregular tubular structures and a small component of granulosa cell differentiation were seen. Immunohistochemically, the neoplastic cells stained positively for oestradiol or testosterone.
- Published
- 1992
- Full Text
- View/download PDF
16. Polymorphism in the tumor necrosis factor B gene is associated with Palmoplantar pustulosis
- Author
-
T. Urushibara, H. Niizeki, K. Hashigucci, Y. Yamazaki, Takeji Nishikawa, M. Yokoyama, T. Tojo, K. Akiya, Yuichiro Yamasaki, and Hiroshi Shimizu
- Subjects
Genetics ,medicine.medical_specialty ,Palmoplantar pustulosis ,business.industry ,Immunology ,Haplotype ,General Medicine ,Biochemistry ,Gastroenterology ,Polymorphism (computer science) ,Internal medicine ,Genotype ,HLA-DR ,medicine ,Immunology and Allergy ,Tumor necrosis factor alpha ,Allele ,business ,Gene - Abstract
We investigated the allele and genotype distribution of a polymorphism of the tumor necrosis factor (TNF) B gene and the frequency of HLA-DR9 in 49 patients with Palmoplantar pustulosis (PPP) and 51 healthy controls. We found that the frequency of TNFB2 in the PPP patients was significantly higher than that in the controls. Furthermore, the DR9-TNFB2 haplotype was significantly more frequent in the PPP patients (P=0.0045). These results suggest that TNFB2 may confer susceptibility to PPP.
- Published
- 1999
- Full Text
- View/download PDF
17. Solitary adrenal metastasis in a patient with sigmoid colon cancer; report of a case
- Author
-
Tomoshige Masuda, O. Matsunami, Nobuichi Kashimura, Y. Shoji, H. Niizeki, M. Dohke, T. Yano, and F. Nakamura
- Subjects
Male ,Pathology ,medicine.medical_specialty ,Colorectal cancer ,medicine.medical_treatment ,Adrenal Gland Neoplasms ,Adenocarcinoma ,Metastasis ,Lesion ,Endocrinology ,Carcinoembryonic antigen ,Fatal Outcome ,Sigmoidectomy ,medicine ,Humans ,Aged ,Chemotherapy ,biology ,business.industry ,Adrenalectomy ,Gastroenterology ,medicine.disease ,Prognosis ,Magnetic Resonance Imaging ,Carcinoembryonic Antigen ,Radiation therapy ,Sigmoid Neoplasms ,Oncology ,biology.protein ,Radiology ,medicine.symptom ,business - Abstract
A 73-year-old man had sigmoidectomy for sigmoid colon cancer in December 2001. Although he was followed regularly with chemotherapy, his serum carcinoembryonic antigen (CEA) increased on August 2002. Abdominal computed tomography and magnetic resonance imaging showed a right adrenal mass and no other abnormality. The preoperative diagnosis was a solitary adrenal metastasis from sigmoid colon cancer; the lesion was removed in September 2002. On pathology, adrenal metastasis was confirmed. Although the patient’s serum CEA normalized soon thereafter, 12 months after adrenalectomy, the CEA again increased; the patient had local recurrence of the resected adrenal lesion and liver metastasis. Therefore, the patient was given systemic chemotherapy, but his condition deteriorated, and he died 38 months after adrenalectomy. Adrenal metastasis from colorectal cancer is not unusual; however, a solitary metastasis is rarely found and resected surgically. As surgical treatment of the metastatic lesion could improve patients’ prognosis to some extent if it is detected early, the possibility of adrenal metastasis should be kept in mind when colorectal cancer patients are followed.
- Published
- 2008
18. Polymorphisms in the tumor necrosis factor (TNF) genes are associated with susceptibility to effects of ultraviolet-B radiation on induction of contact hypersensitivity
- Author
-
H, Niizeki, T, Naruse, K H, Hecker, J R, Taylor, I, Kurimoto, T, Shimizu, Y, Yamasaki, H, Inoko, and J W, Streilein
- Subjects
Membrane Glycoproteins ,Tumor Necrosis Factor-alpha ,Ultraviolet Rays ,Histocompatibility Testing ,Toll-Like Receptors ,Histocompatibility Antigens Class II ,Receptors, Cell Surface ,Dermatitis, Contact ,Polymorphism, Single Nucleotide ,Toll-Like Receptor 4 ,Phenotype ,Gene Frequency ,Immune System ,Drosophila Proteins ,Humans ,Promoter Regions, Genetic ,Polymorphism, Restriction Fragment Length ,Adaptor Proteins, Signal Transducing ,Microsatellite Repeats - Abstract
We investigated the allelic distributions of single nucleotide polymorphisms (SNPs) of the TNFA, TNFB and IKBL genes, 3 microsatellites within the tumor necrosis factor (TNF) region of HLA locus, and the HLA phenotypes as well as the TLR4 gene in Chromosome 9 in 26 healthy Caucasian volunteers. These individuals were also assessed as ultraviolet B (UVB)-susceptible (S) or UVB-resistant (R). Our results identified 12 UVB-S and 14 UVB-R individuals. Attempts to correlate particular HLA-A, -B, -C, and -DR antigens with the UVB phenotypes failed. Similarly, attempts to correlate SNP at the NcoI-RFLP within intron 1 of the TNFB, IKBL and TLR4 gene with UVB phenotypes also failed. However, microsatellite analyses of TNFa, TNFc, and TNFd markers revealed a significant increase in the frequencies of TNFa2 in UVB-S individuals (P=0.00032) and of TNFd3 in UVB-R individuals (P=0.012). Moreover, DNA sequencing analyses of 5 SNPs of the TNFA promoter region revealed a significant increase in the frequency of the allele B of the TNFA gene (TNFApB) representing the nucleotide A at position -863 and C at position -1031 (P=0.015). Since it is known that TNFa2 and TNFApB is a high TNF-alpha responder, whereas TNFd3 is a TNF-alpha low responder, we propose that the TNF region of HLA contains polymorphic genes that confer susceptibility and resistance to the deleterious effects of UVB radiation on the induction of contact hypersensitivity. This proposal is consistent with previous reports that a unique microsatellite region of the Tnfa gene in mice contains alleles that dictate the UVB-dependent phenotypes in mice, and implicate TNF-alpha as the primary mediator of the immune-damaging effects of UVB radiation.
- Published
- 2002
19. Genotyping for HLA-A, B and C alleles in Japanese patients with pemphigus: prevalence of Asian alleles of the HLA-B15 family
- Author
-
S, Miyagawa, H, Niizeki, Y, Yamashina, and T, Kaneshige
- Subjects
Chi-Square Distribution ,Genotype ,HLA-A Antigens ,HLA-B Antigens ,Case-Control Studies ,Humans ,HLA-C Antigens ,Alleles ,Linkage Disequilibrium ,Pemphigus - Abstract
There have been only limited reports on major histocompatibility complex class I antigens in pemphigus.To characterize HLA-A, B and C class I alleles by genotyping in Japanese patients with pemphigus, and to analyse the possible association of class I alleles with disease susceptibility within a relatively homogeneous ethnic population.Alleles of HLA-A, B and C, and DRB1 and DQB1 loci were fully determined in 51 Japanese patients with pemphigus.Asian alleles of the HLA-B15 family, including the allele B*1507, which was significantly increased in comparison with normal controls, were prevalent in patients with pemphigus vulgaris (PV). The prevalence of B*15 alleles in patients with PV was not due to linkage disequilibrium with HLA-DR4 or DR14 alleles, which have been shown to confer strong susceptibility to PV across racial barriers. In contrast to the unique distribution of the HLA-B alleles, HLA-A and C alleles were unremarkable in patients with PV when compared with normal control subjects.These results suggest that there may be differences in the ethnic concentrations of different HLA-B alleles in patients with PV.
- Published
- 2002
20. Polymorphisms in the TNFA promoter region is not associated with palmoplantar pustulosis
- Author
-
H, Niizeki, T, Naruse, K, Hashigucci, M, Yokoyama, Y, Yamasaki, K, Akiya, T, Tojo, T, Urushibara, Y, Yamazaki, H, Inoko, and T, Nishikawa
- Subjects
Genotype ,Tumor Necrosis Factor-alpha ,Humans ,Psoriasis ,HLA-DR Antigens ,Promoter Regions, Genetic ,Lymphotoxin-alpha ,Polymorphism, Single Nucleotide ,HLA-DR Serological Subtypes - Abstract
Polymorphisms of the 5'-flanking promoter/enhancer region of the TNAFA gene were determined in 80 Japanese patients with pulmoplantar pustulosis (PPP). The 5'-flanking region of the TNFA gene from -1107 to 66 was amplified by polymerase chain reaction (PCR) method. Nucleotide sequencing data from the PCR products revealed that 5 single nucleotide polymorphisms at position 1031, -863, -857, -307 and -237. None of the nucleotide substitutions were significantly increased in PPP patients when compared with those in controls. To clarify the linkage among the neighboring genetic marker, we analyzed the association between the polymorphisms in the TNFA promoter region and the NcoI polymorphism in the first intron of the TNFB gene as well as HLA-DR9. The genotype at 1031C is strongly associated with TNFB1 and negatively associated with TNFB2 which is reported to be associated with PPP. These data indicate that TNFA gene centromeric to TNFB is not associated with PPP and the susceptible gene of PPP is located between TNFB and HLA-B.
- Published
- 2000
21. HLA-DRB1 polymorphisms and autoimmune responses to desmogleins in Japanese patients with pemphigus
- Author
-
Masayuki Amagai, Sachiko Miyagawa, T. Kaneshige, Takeji Nishikawa, Toshihiko Shirai, Yukio Yamashina, H. Niizeki, and Hidetoshi Inoko
- Subjects
musculoskeletal diseases ,Genotype ,Immunology ,Peptide binding ,Biochemistry ,Desmoglein ,Autoimmune Diseases ,Japan ,immune system diseases ,Antibody Specificity ,Genetics ,medicine ,Immunology and Allergy ,Humans ,Amino Acid Sequence ,skin and connective tissue diseases ,education ,Peptide sequence ,Pemphigus foliaceus ,Alleles ,Autoantibodies ,education.field_of_study ,Polymorphism, Genetic ,Desmoglein 3 ,Chemistry ,Desmoglein 1 ,Pemphigus vulgaris ,Autoantibody ,General Medicine ,HLA-DR Antigens ,medicine.disease ,Molecular biology ,Cytoskeletal Proteins ,Desmoplakins ,Haplotypes ,Desmogleins ,Pemphigus ,HLA-DRB1 Chains - Abstract
Pemphigus vulgaris (PV) and pemphigus foliaceus (PF) are caused by autoantibodies against keratinocyte adhesion molecules desmoglein 3 (Dsg3) and desmoglein 1 (Dsg1), respectively. To determine possible major histocompatibility complex (MHC) class II associations with autoantibody responses to desmogleins, haplotype and allele distributions, along with molecular polymorphisms of HLA-DR and -DQ genes were analyzed based on the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) results in 85 Japanese patients with pemphigus. Each of 55 PV patients carried at least one allele of HLA-DRB1*04 and DRB1*14 subtypes, with significant increases of HLA-DRB1*0406/DQA1*0301/DQB1*0302, DRB1*14/DQA1*0104/DQB1*05 and DRB1*1406/DQA1*0503/ DQB1*0301 haplotypes compared to normal controls. The HLA-DRB1*04 and DRB*14 alleles carried by PV patients shared hydrophobic amino acid residues Phe26, Leu67 and Val86, as well as hydrophilic amino acid residues at positions 70 and 71 on the DRB1 beta chain. HLA-DR/DQ distributions did not differ among PV patients according to the presence or absence of anti-Dsg1 co-existing with anti-Dsg3. Thirty PF patients, all producing autoantibodies only to Dsg1, showed more diverse HLA-DR/DQ distributions, sharing hydrophobic amino acid residues at positions 26 and 67, as well as hydrophilic amino acid residues at positions 70 and 71, of the DRB1 chain. These findings suggest that autoantibody responses to desmogleins might be regulated by amino acid residues at positions 26, 67, 70, 71 and 86 at peptide binding sites of HLA-DRB1 molecules, and that autoimmune responses to Dsg3 might be more strictly regulated by specific amino acid residues at these positions on the HLA-DRB1 chain than responses to Dsg1.
- Published
- 1999
22. Polymorphism in the tumor necrosis factor B gene is associated with Palmoplantar pustulosis
- Author
-
K, Hashigucci, M, Yokoyama, H, Niizeki, Y, Yamasaki, K, Akiya, T, Tojo, T, Urushibara, Y, Yamazaki, H, Shimizu, and T, Nishikawa
- Subjects
Polymorphism, Genetic ,Genotype ,Humans ,Psoriasis ,Lymphotoxin-alpha ,Alleles - Abstract
We investigated the allele and genotype distribution of a polymorphism of the tumor necrosis factor (TNF) B gene and the frequency of HLA-DR9 in 49 patients with Palmoplantar pustulosis (PPP) and 51 healthy controls. We found that the frequency of TNFB2 in the PPP patients was significantly higher than that in the controls. Furthermore, the DR9-TNFB2 haplotype was significantly more frequent in the PPP patients (P=0.0045). These results suggest that TNFB2 may confer susceptibility to PPP.
- Published
- 1999
23. Calcitonin gene-related peptide is necessary for ultraviolet B-impaired induction of contact hypersensitivity
- Author
-
H, Niizeki, P, Alard, and J W, Streilein
- Subjects
Male ,Mice, Inbred C3H ,Dose-Response Relationship, Drug ,Tumor Necrosis Factor-alpha ,Ultraviolet Rays ,Calcitonin Gene-Related Peptide ,Dermatitis, Contact ,Antibodies ,Mice, Mutant Strains ,Mice ,Langerhans Cells ,Animals ,Dinitrofluorobenzene ,Mast Cells ,Skin - Abstract
Since nerve termini on Langerhans cells (LC) contain calcitonin gene-related peptide (CGRP), and since ultraviolet B radiation (UVR) causes CGRP to be released from cutaneous nerve endings, we examined whether CGRP participates in the immune aberrations caused in skin by UVR. First, intradermally injected CGRP, in a dose-dependent manner, reduced LC density and impaired CH induction when hapten was painted on the injected site. Second, CGRP antagonist restored CH induction after UVR. Third, anti-TNF-alpha Abs injected before CGRP prevented the loss of LC density and restored CH induction. Fourth, CGRP failed to impair CH induction in mast cell-deficient mice. Fifth, CGRP induced mast cells to release TNF-alpha. We conclude that CGRP plays an essential role in the loss of CH induction after UVR. These data indicate that UVR, by causing the release of CGRP from cutaneous nerve endings, triggers mast cell release of TNF-alpha, which impairs CH induction.
- Published
- 1998
24. [An experience with omentopexy for the repair of postoperative bronchopleural fistula]
- Author
-
N, Takenouchi, T, Shiono, Y, Sekishita, M, Fujimori, Y, Sato, T, Munemura, S, Ootake, H, Niizeki, and T, Oshikiri
- Subjects
Male ,Postoperative Complications ,Fistula ,Humans ,Bronchial Fistula ,Fibrin Tissue Adhesive ,Middle Aged ,Pleural Diseases ,Pneumonectomy ,Omentum - Abstract
Postoperative bronchopleural fistula has been the most troublesome complications in the thoracic surgery. In this report, we presented a case of bronchopleural fistula successfully closed by omentopexy. A 51-year-old man had undergone left upper lobectomy and S6 segmentectomy for primary lung cancer. Bronchopleural fistula due to postoperative pneumonia was developed and completion pneumonectomy with the intercostal-musclo-pexy was performed. Post-re-operative course was unsuccessful, bronchopleural fistula remained, so we tried re-closure of the bronchial stump by omentopexy without thoracoplasty or muscle flap plombage. About a half year after 3rd operation, he relapsed into bronchopleural fistula. Then fibrin gluing was performed via a flexible fiberoptic bronchoscope without hospitalization, and the omental flap was fixed completely to the bronchial stump. We believe the omentopexy a useful procedure for treating postoperative bronchopleural fistula which can't make any chest-wall deformation.
- Published
- 1997
25. HLA-DQA1, -DQB1 and -DRB1 genotyping in Japanese pemphigus vulgaris patients by the PCR-RFLP method
- Author
-
Takeji Nishikawa, Kyoko Watababe, Nobuhisa Mizuki, Takashi Hashimoto, Nobuko Inamoto, H. Niizeki, and Hidetoshi Inoko
- Subjects
musculoskeletal diseases ,Linkage disequilibrium ,endocrine system diseases ,Genotype ,Immunology ,Genes, MHC Class II ,Human leukocyte antigen ,Biology ,Biochemistry ,Polymerase Chain Reaction ,HLA-DQ alpha-Chains ,Gene Frequency ,Japan ,immune system diseases ,HLA-DQ Antigens ,HLA-DQ ,Genetics ,HLA-DR ,medicine ,Immunology and Allergy ,HLA-DQ beta-Chains ,Humans ,Genetic Predisposition to Disease ,skin and connective tissue diseases ,Genotyping ,Alleles ,Pemphigus vulgaris ,nutritional and metabolic diseases ,General Medicine ,HLA-DR Antigens ,medicine.disease ,Disease Susceptibility ,Restriction fragment length polymorphism ,Pemphigus ,Polymorphism, Restriction Fragment Length ,HLA-DRB1 Chains - Abstract
We performed HLA-DQA1, -DQB1 and -DRB1 genotyping using the PCR-RFLP (polymerase chain reaction-restriction fragment length polymorphism) method for 32 Japanese pemphigus vulgaris (PV) patients. There was a significant association of either DQB1*0503 or DRB1*1405 with PV, and a negative association of either DQA1*0103 or DQB1*0601 with PV was found. Since the DQB1*0503+ patients had various DR14-related alleles, we concluded that the association with DQB1 is primary and that the association with DRB1 is simply due to linkage disequilibrium between the DQ and DR genes. These results may indicate that specific HLA class II antigens confer the susceptibility to PV among Japanese.
- Published
- 1994
26. Intestinal Behçet disease: serial changes at radiography
- Author
-
Tadahiko Fuchigami, Tsuneyoshi Yao, Masatoshi Fujishima, Mitsuo Iida, Mitsuo Okada, H Niizeki, Takeshi Matsumoto, and Hiroyuki Kobayashi
- Subjects
Adult ,Male ,medicine.medical_specialty ,Time Factors ,Eye disease ,Radiography ,Radiologic sign ,Recurrence ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,Ulcer ,Barium enema ,Entire colon ,Medical treatment ,Behcet disease ,business.industry ,Behcet Syndrome ,Middle Aged ,medicine.disease ,digestive system diseases ,Surgery ,Barium meal ,Intestinal Diseases ,Female ,business ,Follow-Up Studies - Abstract
To clarify the characteristic radiographic findings and serial radiographic changes in nonsurgical cases of intestinal Behçet disease (BD), seven patients were followed up for an average of 4 1/2 years (range, 8 months to 11 years 4 months). They underwent repeated examination with barium meal studies and double-contrast barium enema meal studies and double-contrast barium enema radiography. Initial radiography revealed one to three deep ulcers in the terminal ileum or ileocecal region in five patients. The ulcers healed while patients were treated with medical therapy but recurred during the follow-up period. In four of these five patients, follow-up radiography demonstrated various changes within each case: At each examination, an enlarged ulcer or a newly developed ulcer was often found in conjunction with a healed ulcer. In the other two patients, multiple shallow ulcers or innumerable aphthoid ulcers were seen throughout the entire colon, and these ulcers showed a good response to medical treatment. These results indicate that serial radiographic changes in patients with intestinal BD may mimic those in patients with Crohn disease, with findings in the terminal ileum and colon that wax and wane with medical treatment.
- Published
- 1993
27. Inhibition of programmed cell death by cyclosporin A; preferential blocking of cell death induced by signals via TCR/CD3 complex and its mode of action
- Author
-
D, Yasutomi, C, Odaka, S, Saito, H, Niizeki, H, Kizaki, and T, Tadakuma
- Subjects
CD3 Complex ,Dose-Response Relationship, Drug ,Cell Survival ,T-Lymphocytes ,DNA ,In Vitro Techniques ,Endocytosis ,Tacrolimus ,Mice ,Isoantibodies ,Cyclosporine ,Animals ,Interleukin-2 ,Calcium ,Cells, Cultured ,Research Article - Abstract
Cyclosporin A (CsA) is reported to inhibit programmed cell death. We confirmed this by using T-cell hybridomas which are inducible to programmed cell death by activation with immobilized anti-CD3 antibody or with anti-Thy 1.2 antibody. Cell death and DNA fragmentation, characteristic features of programmed cell death, were almost completely blocked by CsA or FK506. To investigate whether CsA inhibits only the cell death through the signals via the TCR/CD3 complex or all of the programmed cell death induced by various reagents, we further established CD4+8+ thymic lymphomas which result in programmed cell death after activation with calcium ionophore, dexamethasone, cyclic AMP or anti-CD3 antibody. It was revealed that CsA could block only the cell death mediated by the TCR/CD3 complex. For the clarification of the site of action of CsA, Ca2+ influx and endocytosis of receptors after stimulation with anti-CD3 antibody were monitored in the presence of CsA, and no significant effects of CsA were observed. Furthermore, prevention of cell death was examined by adding CsA at various periods of time after initiation of culture. CsA was found to exert its effect even when added after 4 h of cultivation, and the kinetic pattern of suppression was similar to that of the suppressive effect on IL-2 production. These observations indicate that in the events of programmed cell death, the major site of action of CsA will not be the inhibition of the immediate membrane events after activation of the TCR/CD3 complex but rather the interference in the function of molecules that transmit signals between membrane events and the activation of genes in the nucleus.
- Published
- 1992
28. [Polymorphisms of HLA class II antigens in 33 Japanese pemphigus patients]
- Author
-
H, Niizeki
- Subjects
Polymorphism, Genetic ,Asian People ,Japan ,Histocompatibility Antigens Class II ,Humans ,Serotyping ,Pemphigus ,Polymorphism, Restriction Fragment Length - Abstract
The HLA class II antigens in 33 Japanese pemphigus patients were investigated by both serologic and restriction fragment length polymorphism (RFLP) analyses: 17 cases of pemphigus vulgaris (PV), 13 cases of pemphigus foliaceus (PF), 3 cases of unclassified pemphigus. In serologic typing, DR2 was absent in PV. DR5, DRw6, DRw12, and DRw52 were positively associated with PV. DQw1 was positively associated with PF. RFLP analyses showed that DRw6 PV patients had a disease-associated restriction fragment representing DQw5, the same association as that found in DRw6 Jewish PV patients. On the other hand, all 13 PF patients were serologically typed for DQw1, which could not be further subdivided into DQw5 by RFLP analyses. These results suggest that Japanese and Jewish PV patients may be immunogenetically closely related to each other, but Japanese PV patients appear to be immunogenetically different from Japanese PF patients.
- Published
- 1991
29. Hard x-ray polarimeter utilizing Compton scattering
- Author
-
M. Noma, Hirohisa Sakurai, and H. Niizeki
- Subjects
Physics ,X-ray astronomy ,business.industry ,Compton scattering ,Polarimetry ,X-ray optics ,Polarimeter ,Electron ,Scintillator ,Polarizer ,law.invention ,Optics ,law ,business - Abstract
The paper describes a 50-cm-diam prototype of a novel Compton-scattering-type polarimeter for hard X-rays in the energy range 30-100 keV. The characteristics of the prototype polarimeter were investigated for various conditions. It was found that, with polarized X-rays from a simple polarizer, the detection efficiency and the modulation factor of the polarimeter with a 40-mm thick scatterer were 3.2 percent and 0.57 percent, respectively, at about 60 keV.
- Published
- 1991
- Full Text
- View/download PDF
30. [HLA antigens in 11 cases of patients with recurrent erythema and anti-SS-B antibody]
- Author
-
H, Niizeki, Y, Amano, T, Hashimoto, T, Nishikawa, and A, Sonoda
- Subjects
Erythema ,HLA Antigens ,Recurrence ,Antibodies, Antinuclear ,Humans - Abstract
HLA antigens were studied in 11 cases of patients with recurrent erythema and anti-SS-B antibody. Among DR antigens positive associations with DR5, DRw6 (including DRw13), and DRw52 were obtained. These data demonstrated that 11 cases of this report are immunogenetically closely related to each other and appear to be related to Sjögren's/lupus erythematosus overlap patients.
- Published
- 1990
31. The production of anti-desmosome monoclonal antibodies
- Author
-
Oy. Amano, A. Konohana, H. Niizeki, Takashi Hashimoto, and Tohru Nishikawa
- Subjects
medicine.anatomical_structure ,business.industry ,Desmosome ,medicine.drug_class ,Medicine ,Dermatology ,business ,Monoclonal antibody ,Molecular Biology ,Biochemistry ,Virology - Published
- 1990
- Full Text
- View/download PDF
32. Studies on the Resistance of Cultivated and Wild Rice to the Blast Disease : I. Resistance of Seedlings to 4 Races of the Fungus
- Author
-
H Niizeki and Y Yamazaki
- Subjects
biology ,Resistance (ecology) ,Botany ,Fungus ,biology.organism_classification ,Blast disease - Published
- 1964
- Full Text
- View/download PDF
33. [Zieve's syndrome]
- Author
-
H, Sibata, H, Toyama, H, Nukata, H, Niizeki, and Y, Tamechika
- Subjects
Adult ,Fatty Liver ,Male ,Alcoholism ,Anemia, Hemolytic ,Humans ,Hyperlipidemias ,Syndrome - Published
- 1975
34. Sheep-associated malignant catarrhal fever of beef cattle in Japan
- Author
-
Y Nakajima, Y Murakami, H Niizeki, and A Taneichi
- Subjects
Veterinary medicine ,Pregnancy ,Sheep ,General Veterinary ,General Medicine ,Beef cattle ,Biology ,medicine.disease ,Epithelium ,Japan ,Malignant Catarrh ,medicine ,Animals ,Cattle ,Female ,Lymphocytes - Published
- 1986
35. Lack of cutis verticis gyrata is associated with c.1279_1290del12 of SLCO2A1 in 43 Japanese patients with pachydermoperiostosis.
- Author
-
Niizeki H, Tanaka R, Nomura T, Seki A, Miyasaka M, Matsumoto Y, Ishibashi M, Narumi S, Nakabayashi K, and Yoshida K
- Subjects
- Adult, Female, Humans, Male, Middle Aged, Asian People genetics, East Asian People, Japan, Organic Anion Transporters genetics, Osteoarthropathy, Primary Hypertrophic genetics, Osteoarthropathy, Primary Hypertrophic diagnosis
- Abstract
Competing Interests: Conflicts of Interest The authors have no conflict of interest to declare.
- Published
- 2024
- Full Text
- View/download PDF
36. An epidemiological survey of anhidrotic/hypohidrotic ectodermal dysplasia in Japan: High prevalence of allergic diseases.
- Author
-
Inazawa-Terada M, Namiki T, Omigawa C, Fujimoto T, Munetsugu T, Ugajin T, Shimomura Y, Ohshima Y, Yoshida K, Niizeki H, Hayashi R, Nakano H, and Yokozeki H
- Subjects
- Humans, Japan epidemiology, Prevalence, Surveys and Questionnaires, Ectodermal Dysplasia diagnosis, Ectodermal Dysplasia 1, Anhidrotic complications, Ectodermal Dysplasia 1, Anhidrotic epidemiology, Ectodermal Dysplasia 1, Anhidrotic genetics
- Abstract
Anhidrotic/hypohidrotic ectodermal dysplasia (A/HED) is a congenital disorder characterized by anhidrosis/hypohidrosis and inadequate hair and dental dysplasia. Large-scale case studies of patients with A/HED have already been conducted overseas, while there has been no large-scale study, but only a few case reports in Japan. Furthermore, an epidemiological study of this disease has not been conducted in Japan to date. The purpose of this study was to investigate the clinical characteristics of A/HED patients, the status of genetic aberrations and complications of A/HED in Japan. Initially, we conducted a physician-initiated questionnaire survey of A/HED patients who visited medical institutions across Japan to investigate their backgrounds, clinical symptoms, genotypes, diagnostic methods and complications of A/HED. We also investigated the presence or absence of various allergic diseases (atopic dermatitis-like skin manifestations, bronchial asthma and food allergies). Questionnaires were also obtained from 26 patients with ectodermal dysplasia (ED) who visited four medical institutions. We compared the incidence of allergic diseases in healthy controls in a similar study to that of patients. Twenty-four of those patients were considered to have A/HED, of which 18 had a confirmed genetic diagnosis and were genotyped. All patients had anhidrosis or hypohidrosis, hair and dental dysplasia, and unique facial appearance; 23 patients had several cutaneous manifestations and seven patients had periorbital pigmentation. In addition, there was a significantly higher incidence of atopic dermatitis-like cutaneous manifestations, bronchial asthma and food allergies in the A/HED patients than in healthy controls. We report the results from a questionnaire survey of 24 patients with A/HED. This is the first report of a large number of A/HED patients in Japan. This study clarifies the status of clinical diagnosis and genetic testing of A/HED patients in Japan, as well as the characteristics of their skin symptoms and allergic complications., (© 2021 Japanese Dermatological Association.)
- Published
- 2022
- Full Text
- View/download PDF
37. Role of Prostaglandin E-Major Urinary Metabolite Levels in Identifying the Phenotype of Pachydermoperiostosis.
- Author
-
Ishibashi M, Oiwa T, Nomura T, Yoshikawa Y, Niizeki H, and Kabashima K
- Subjects
- Adolescent, Adult, Alleles, Biomarkers urine, Case-Control Studies, Hand, Humans, Hydroxyprostaglandin Dehydrogenases genetics, Male, Middle Aged, Mutation, Organic Anion Transporters genetics, Phenotype, Young Adult, Osteoarthropathy, Primary Hypertrophic diagnosis, Osteoarthropathy, Primary Hypertrophic urine, Prostaglandins E urine, Prostanoic Acids urine
- Published
- 2021
- Full Text
- View/download PDF
38. Successful Treatment with Hepatic Arterial Infusion Chemotherapy in a Breast Cancer Patient with Multiple Liver Metastases Who Declined Systemic Therapy.
- Author
-
Masuda T, Niizeki O, Niizeki T, Fujiyoshi K, Ando Y, Niizeki H, and Mimori K
- Abstract
Despite improvements in systemic medical therapy (ST), liver metastases (LMs) are a poor prognostic factor in metastatic breast cancer (MBC) patients. We describe a MBC patient with predominant LMs treated with hepatic arterial infusion chemotherapy (HAIC) who declined ST. Moreover, we assessed general health status during treatment using C-reactive protein (CRP)/albumin ratio (CAR) and peripheral platelet count × CRP multiplier (P-CRP), well-known indicators of systemic inflammatory response. A 64-year-old woman who underwent a total mastectomy with axillary lymph node dissection for an HR-positive, HER2-negative infiltrating ductal BC developed multiple liver, lung, lymph node, and bone metastases. She received ST including paclitaxel plus the anti-vascular endothelial growth factor antibody, bevacizumab, hormone therapy with high-dose toremifene, the oral 5-fluorouracil derivative, S-1, and eribulin. She then declined ST because of the toxicity or decreased treatment motivation thereof, and opted for HAIC with 5FU plus epirubicin followed by Taxane for 1 year and 1 month. Computed tomography revealed a partial response or stable disease in the liver and slow progression in other sites without symptoms or side effects and decreased CEA and CA15-3 levels. The CAR and P-CRP remained low. She survived for 1 year and 3 months after the start of HAIC. This case reveals that HAIC may be an option for advanced BC patients with LMs who cannot receive ST., Competing Interests: All the authors declare no conflicts of interest., (Copyright © 2021 by S. Karger AG, Basel.)
- Published
- 2021
- Full Text
- View/download PDF
39. Eicosanoid profiling in patients with complete form of pachydermoperiostosis carrying SLCO2A1 mutations.
- Author
-
Oiwa T, Ishibashi M, Okuno T, Ohba M, Endo Y, Uozumi R, Ghazawi FM, Yoshida K, Niizeki H, Yokomizo T, Nomura T, and Kabashima K
- Subjects
- Dinoprostone, Eicosanoids, Humans, Mutation, Organic Anion Transporters genetics, Osteoarthropathy, Primary Hypertrophic diagnosis, Osteoarthropathy, Primary Hypertrophic genetics
- Abstract
Pachydermoperiostosis (PDP) is a genetic disease characterized by digital clubbing, periostosis, and pachydermia caused by mutated HPGD or SLCO2A1. Plasma prostaglandin (PG)E
2 levels are increased in these patients. However, other eicosanoids have not been quantitated. We aimed to quantitate plasma eicosanoid levels in four patients carrying SLCO2A1 mutations by high-performance liquid chromatography-tandem mass spectrometry. PGE2 level was elevated in all patients; PGD2 and 11β-PGF2 α levels were also increased in some patients, whereas eicosapentaenoic acid, docosahexaenoic acid, and arachidonic acid levels were decreased in all patients. Our data indicate a dysfunctional eicosanoid homeostasis and varied levels of PG in patients with a complete form of PDP carrying SLCO2A1 mutations. PGE2 levels seem to mostly affect the symptoms, with other eicosanoids possibly having a minor effect., (© 2021 Japanese Dermatological Association.)- Published
- 2021
- Full Text
- View/download PDF
40. Primary hypertrophic osteoarthropathy with severe arthralgia identified by gene mutation of SLCO2A1 .
- Author
-
Ishizuka T, Fujioka K, Mori I, Takeda T, Fuwa M, Ikeda T, Taguchi K, Morita H, Nakabayashi K, and Niizeki H
- Subjects
- Adult, Humans, Male, Mutation, Arthralgia diagnosis, Arthralgia genetics, Organic Anion Transporters genetics, Osteoarthropathy, Primary Hypertrophic diagnosis, Osteoarthropathy, Primary Hypertrophic genetics
- Abstract
Male, 41 years old (yo) had been complaining of severe arthralgia. Past History indicated obstruction of intestinal tract at 12 yo and gastric ulcer at 13 yo. He had been suffered from polyarthralgia especially at PIP and MP joints of both hands from 38 yo. Finally, he complained severe arthralgia at PIP and MP joints with clubbed fingers without swelling. Biochemical finding indicated negative rheumatoid factor and anti-CCP antibody and normal MMP-3 level, but slightly increased CRP and ESR levels. Radiological finding indicated periostosis of long bone without bone erosion and osteoporosis. His facial appearance was acromegalic with cutaneous manifestation of pachydermia and cutis vertices gyrate without abnormal growth hormone response. Histological findings of skin indicated oedema and hyperplasia of sebaceous glands with infiltration of lymphocytes around small blood vessels compatible with pachydermoperiostosis. In this case mutation of SLCO2A1 gene, which coded prostaglandin transport protein, was identified. The mutation c.940 + 1G > A of SLCO2A1 gene results in deletion of exon 7 and truncation of PG transporter (p.Arg288Glyfs*7). We suggest that severe arthralgia was originated from over production of prostaglandin E2. Further studies will be required.
- Published
- 2021
- Full Text
- View/download PDF
41. A Distinct Feature of T Cell Subpopulations in a Patient with CHARGE Syndrome and Omenn Syndrome.
- Author
-
Uchiyama T, Kawakami S, Masuda H, Yoshida K, Niizeki H, Mochizuki E, Edasawa K, Ishiguro A, and Onodera M
- Subjects
- Biomarkers, CHARGE Syndrome etiology, DNA Helicases genetics, DNA-Binding Proteins genetics, Heterozygote, Humans, Immunophenotyping, Lymphocyte Count, Male, Mutation, Phenotype, Severe Combined Immunodeficiency etiology, T-Lymphocyte Subsets metabolism, CHARGE Syndrome complications, CHARGE Syndrome diagnosis, Severe Combined Immunodeficiency complications, Severe Combined Immunodeficiency diagnosis, T-Lymphocyte Subsets immunology
- Published
- 2021
- Full Text
- View/download PDF
42. Safety and Efficacy of the Sirolimus Gel for TSC Patients With Facial Skin Lesions in a Long-Term, Open-Label, Extension, Uncontrolled Clinical Trial.
- Author
-
Wataya-Kaneda M, Nagai H, Ohno Y, Yokozeki H, Fujita Y, Niizeki H, Yoshida K, Ogai M, Yoshida Y, Asahina A, Fukai K, Tateishi C, Hamada I, Takahata T, Shimizu K, Shimasaki S, and Murota H
- Abstract
Introduction: Our previous clinical studies have demonstrated the short-term efficacy and safety of the sirolimus gel for patients with tuberous sclerosis complex (TSC). However, long-term clinical evidence is lacking. Our objective was to assess the safety and efficacy of long-term treatment with the sirolimus gel for the skin lesions of TSC patients., Methods: We conducted a multicenter, open-label, uncontrolled clinical trial in 94 Japanese patients with TSC. Patients applied the 0.2% sirolimus gel on their face or head twice daily for > 52 weeks (maximum 136 weeks for safety). The safety endpoints were the rate of adverse event (AE)-caused discontinuation (primary endpoint) and the incidence of AEs. The efficacy endpoint was the response rate of angiofibromas, cephalic plaques, and hypomelanotic macules., Results: Among 94 enrolled patients (mean age, 21 years; range 3-53 years), the rate of AE-caused discontinuation was 2.1% (2/94 patients). Although application site irritation and dry skin occurred relatively frequently, none of the drug-related AEs were serious; most of the drug-related AEs resolved rapidly. The major drug-related AEs (≥ 5% in incidence) were application site irritation (30.9%), dry skin (27.7%), acne (20.2%), eye irritation (8.5%), pruritus (8.5%), erythema (7.4%), dermatitis acneiform (6.4%), and dermatitis contact (5.3%). The response rates of angiofibromas, cephalic plaques, and hypomelanotic macules were 78.2% [95% confidence interval (CI) 68.0-86.3%], 66.7% (95% CI 51.1-80.0%), and 72.2% (95% CI 46.5-90.3%), respectively., Conclusions: The gel was well tolerated for a long time by patients with TSC involving facial skin lesions and continued to be effective., Trial Registration: ClinicalTrials.gov identifier: NCT02634931.
- Published
- 2020
- Full Text
- View/download PDF
43. Congenital nail clubbing.
- Author
-
Nakazawa S, Niizeki H, Nakabayashi K, Tanese K, and Tokura Y
- Subjects
- Adult, Humans, Hydroxyprostaglandin Dehydrogenases genetics, Male, Nail Diseases congenital, Nail Diseases genetics, Nail Diseases urine, Organic Anion Transporters genetics, Osteoarthropathy, Primary Hypertrophic genetics, Osteoarthropathy, Primary Hypertrophic pathology, Osteoarthropathy, Primary Hypertrophic urine, Prostaglandins urine, Skin pathology, Nail Diseases diagnosis, Osteoarthropathy, Primary Hypertrophic diagnosis
- Published
- 2019
- Full Text
- View/download PDF
44. Linear keratinocytic epidermal nevi on trunk skin caused by a somatic FGFR2 p.C382R mutation.
- Author
-
Tanaka R, Umegaki-Arao N, Sasaki T, Aoki S, Yoshida K, Niizeki H, and Kubo A
- Subjects
- Biopsy, Child, Preschool, DNA Mutational Analysis, Female, Humans, Mutation, Nevus pathology, Skin pathology, Skin Neoplasms pathology, Torso, Nevus genetics, Receptor, Fibroblast Growth Factor, Type 2 genetics, Skin Neoplasms genetics
- Published
- 2018
- Full Text
- View/download PDF
45. A male Korean who was diagnosed with chronic enteropathy associated with SLCO2A1 (CEAS): case report with literature review.
- Author
-
Sun X, Hosoe N, Miyanaga R, Kimura K, Mizuno S, Takabayashi K, Naganuma M, Niizeki H, Seki A, Ogata H, and Kanai T
- Abstract
Objective: To further disseminate the nomenclature of chronic enteropathy associated with SLCO2A1 (CEAS), especially for physicians in China and Korea where the genetic feature of SLCO2A1 gene mutations related hypertrophic osteoarthropathy and pachydermia had been extensively studied. SLCO2A1 gene mutations related hypertrophic osteoarthropathy and pachydermia had been extensively studied., Design: A case report with literature review of SLCO2A1 gene mutations-related disorders., Results: A 38-year-old Korean presented to a tertiary hospital with dizziness, abdominal pain and melena. He had a positive faecal occult blood test on initial workup. Oesophagogastroduodenal endoscopy (OGD), colonoscopy and CT scan were unremarkable and showed no obvious cause for his melena. Capsule endoscope and roentgen barium studies were performed, revealing an erythematous mucosa with ulcers in the jejunum and stenosis to the jejunal-ileal junction. Next-generation sequencing was then performed and discovered point mutations of SLCO2A1 gene's seven exon (940+1 G>A) and 13 exon (1807 C>T) allele. This Korean patient with CEAS is the first documented case noted outside of the Japanese population., Conclusion: CEAS is not uniquely found in Japanese individuals. There are lots of similarities between CEAS and primary hypertrophic osteoarthropathy, the two entity may just be the two sides of one same coin. International and multidisciplined efforts are required to further study this complicated disorder., Competing Interests: Competing interests: None declared.
- Published
- 2018
- Full Text
- View/download PDF
46. Sirolimus Gel Treatment vs Placebo for Facial Angiofibromas in Patients With Tuberous Sclerosis Complex: A Randomized Clinical Trial.
- Author
-
Wataya-Kaneda M, Ohno Y, Fujita Y, Yokozeki H, Niizeki H, Ogai M, Fukai K, Nagai H, Yoshida Y, Hamada I, Hio T, Shimizu K, and Murota H
- Subjects
- Administration, Cutaneous, Adolescent, Adult, Angiofibroma etiology, Child, Double-Blind Method, Facial Neoplasms etiology, Female, Gels, Humans, Immunosuppressive Agents adverse effects, Male, Middle Aged, Placebos therapeutic use, Sirolimus adverse effects, Skin Neoplasms etiology, Young Adult, Angiofibroma drug therapy, Facial Neoplasms drug therapy, Immunosuppressive Agents therapeutic use, Sirolimus therapeutic use, Skin Neoplasms drug therapy, Tuberous Sclerosis complications
- Abstract
Importance: Most patients with tuberous sclerosis complex (TSC), an autosomal-dominant disorder that is caused by the constitutive activation of mammalian target of rapamycin, experience disfigurement caused by skin lesions involving facial angiofibromas. Many have been left untreated because of a lack of therapeutic options that are less invasive than surgery or laser treatment., Objective: To confirm the efficacy and safety of sirolimus gel, 0.2%, for treatment of patients with angiofibromas and/or skin lesions., Design, Setting, and Patients: Multicenter, randomized clinical trial at 9 centers in Japan from December 2015 to October 2016 including 62 children and adults with TSC., Interventions: Patients who developed angiofibromas were randomly assigned, in a 1:1 ratio, to receive sirolimus gel, 0.2%, or placebo, each applied topically twice daily for 12 weeks., Main Outcomes and Measures: The primary end point was composite improvement in the size and color of angiofibromas in photographs at week 12 of treatment. It was assessed by an independent review committee comprising 3 blinded dermatologists who categorized patient results into the following 6 categories: "markedly improved," "improved," "slightly improved," "unchanged," "slightly aggravated," and "aggravated.", Results: Sixty-two patients (27 pediatric and 35 adult; 34 [55%] female; mean [SD] age, 22.5 [11.9] years) were enrolled and randomly assigned to receive sirolimus gel, 0.2% (30 patients), or placebo (32 patients). The response rates of angiofibromas at weeks 4, 8, and 12 of treatment were 0 each in the placebo group in contrast to 20% (95% CI, 8%-39%; P = .01), 43% (95% CI, 26%-63%; P < .001), and 60% (95% CI, 41%-77%; P < .001), respectively, in the sirolimus group. None of the 31 assessable patients in the placebo group were rated improved or better, and 26 of them (84%) were rated unchanged. In contrast, 5 (17%) and 13 (43%) patients in the sirolimus group were rated markedly improved and improved, respectively. Adverse events were mild to moderate and were observed in 27 (90%) and 22 (69%) patients in the sirolimus and placebo groups, respectively; however, none of the trial participants discontinued treatment. Acute pancreatitis developed as a serious adverse event in 1 patient in the sirolimus group, and the patient recovered soon after hospitalization without discontinuing treatment., Conclusions and Relevance: Sirolimus gel, 0.2%, demonstrated a significant clinical benefit for patients with TSC involving angiofibromas, thus providing a promising therapeutic modality., Trial Registration: ClinicalTrials.gov Identifier: NCT02635789.
- Published
- 2018
- Full Text
- View/download PDF
47. Japanese case of xeroderma pigmentosum complementation group C with a novel mutation.
- Author
-
Tamesada Y, Nakano E, Tsujimoto M, Masaki T, Yoshida K, Niizeki H, and Nishigori C
- Subjects
- Codon, Nonsense, Early Diagnosis, Hospitals, University, Humans, Infant, Japan, Male, Sequence Analysis, DNA, Skin Aging, Skin Neoplasms prevention & control, DNA-Binding Proteins genetics, Rare Diseases diagnosis, Rare Diseases genetics, Xeroderma Pigmentosum diagnosis, Xeroderma Pigmentosum genetics
- Published
- 2018
- Full Text
- View/download PDF
48. Effectiveness of non-steroidal anti-inflammatory drugs among patients with primary hypertrophic osteoarthropathy: A systematic review.
- Author
-
Shakya P, Pokhrel KN, Mlunde LB, Tan S, Ota E, and Niizeki H
- Subjects
- Dinoprostone biosynthesis, Humans, Osteoarthropathy, Primary Hypertrophic genetics, Osteoarthropathy, Primary Hypertrophic pathology, Rare Diseases genetics, Rare Diseases pathology, Treatment Outcome, Cyclooxygenase Inhibitors therapeutic use, Dinoprostone antagonists & inhibitors, Osteoarthropathy, Primary Hypertrophic drug therapy, Rare Diseases drug therapy
- Abstract
Background: Primary hypertrophic osteoarthropathy (PHO), also known as pachydermoperiostosis is a rare genetic disease which predominantly affects skin, bone and soft connective tissue. It is characterized by the triad of pachydermia, digital clubbing and periostosis of long bones. Arthralgia or arthritis is also present in most of the cases. Genetic studies have identified the impaired PGE2 metabolism as a culprit for hypertrophic osteoarthropathy in PHO cases. We conducted a systematic review to examine the effectiveness of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), a PGE2 synthesis blocker to reduce the symptoms among PHO patients., Methods: We searched the evidence in five databases; Cochrane Library, CINAHL, EMBASE, MEDLINE, and PubMed. We reported the evidence using narrative synthesis., Results: Out of 238 identified studies, we selected 26 for the synthesis. All were case reports which included a total of 54 patients. Among them, 39 patients were treated with at least one type of NSAIDs. Around 70% of the patients treated with NSAIDs had clinical improvement for their symptoms, mostly arthritis or arthralgia symptoms., Conclusion: NSAIDs were effective in improving arthralgia or arthritis symptoms in majority of the PHO patients. Therefore, we recommend the use of NSAIDs in PHO patients to treat arthralgia or arthritis., (Copyright © 2017. Published by Elsevier B.V.)
- Published
- 2018
- Full Text
- View/download PDF
49. Delayed-onset heat intolerance in a Japanese patient with X-linked hypohidrotic ectodermal dysplasia associated with a large deletion involving four genes.
- Author
-
Niizeki H, Hayashi R, Naiki Y, Yoshida K, Tanaka R, Shimizu A, Terashima H, Isogawa N, Abe R, and Shimomura Y
- Subjects
- Age of Onset, Child, Preschool, Ectodermal Dysplasia 1, Anhidrotic diagnosis, Genetic Testing, Heat Stress Disorders diagnosis, Humans, Male, Pedigree, Sequence Deletion, Ectodermal Dysplasia 1, Anhidrotic genetics, Heat Stress Disorders genetics
- Published
- 2018
- Full Text
- View/download PDF
50. Complete type of pachydermoperiostosis with a novel mutation c.510G>A of the SLCO2A1 gene.
- Author
-
Nakazawa S, Mori T, Niizeki H, Nakabayashi K, and Tokura Y
- Subjects
- Adult, Genotype, Humans, Male, Mutation, Phenotype, Organic Anion Transporters genetics, Osteoarthropathy, Primary Hypertrophic genetics
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.